Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction.
暂无分享,去创建一个
Y. Gruel | E. Rideau | Y. Lebranchu | S. Iochmann | P. Bardos | P. Reverdiau-Moalic | S. Beaujean | Yvon Lebranchu | Yves Gruel | P. Bardos | Sonia Beaujean | Elisabeth Rideau
[1] P. Sandset. Tissue factor pathway inhibitor (TFPI) , 1999 .
[2] A. Siegbahn,et al. Tissue factor expression in human monocytic cell lines. , 1997, Thrombosis research.
[3] P. Tipping,et al. Tissue factor pathway inhibitor expression in atherosclerosis. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[4] J. Fallon,et al. Tissue Factor in the Pathogenesis of Atherosclerosis , 1997, Thrombosis and Haemostasis.
[5] N. Semeraro,et al. Tissue Factor in Health and Disease , 1997, Thrombosis and Haemostasis.
[6] A. Stephens,et al. Suppression of human monocyte tissue factor synthesis by antisense oligodeoxynucleotide. , 1997, Thrombosis research.
[7] P. Sandset. Tissue factor pathway inhibitor (TFPI)--an update. , 1996, Haemostasis.
[8] K. Vrana,et al. Use of elevated reverse transcription reaction temperatures in RT-PCR. , 1996, BioTechniques.
[9] A. Stephens,et al. Co-localization of tissue factor protein and its mRNA in human blood monocytes. , 1996, Thrombosis research.
[10] A. Kolstø,et al. Cell biology of tissue factor, the principal initiator of blood coagulation. , 1996, Thrombosis research.
[11] Y. Gruel,et al. A simplified and low-cost one-stage chromogenic assay for tissue factor dependent procoagulant activity of endothelial cells. , 1995, Thrombosis research.
[12] Y. Gruel,et al. Tissue Factor Activity of Syncytiotrophoblast Plasma Membranes and Tumoral Trophoblast Cells in Culture , 1995, Thrombosis and Haemostasis.
[13] M. McGee,et al. Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation , 1994, The Journal of experimental medicine.
[14] D. Ruiter,et al. Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. , 1994, Thrombosis and haemostasis.
[15] H. Saito,et al. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Crossman,et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. , 1990, The Journal of biological chemistry.
[17] J. Sadler,et al. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. , 1989, The Journal of biological chemistry.
[18] M. V. Doyle,et al. Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Miletich,et al. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. , 1988, The Journal of biological chemistry.
[20] K. Williams,et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[21] W. Fiers,et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Kao,et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. , 1985, Nucleic acids research.
[23] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.